Add to ORKGAcknowledgments: The authors would like to thank Giuseppe San-guineti, MD, for reviewing the manu-script. Conflict of interest statement: No fi-nancial or other relationships that might lead to a conflict of interest are present
Published online ahead of print at www.jco.org on March 10, 2014. Both M.O. and T.I. contributed equ...
Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or...
reaction. Oral anticancer agents such as gefitinib are gener-ally thought to be safer than other ant...
diotherapy, three-dimensional confor-mal radiotherapy. Conflict of interest: None. On behalf of all ...
response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal...
authors declare no potential conflicts of interest. Acknowledgments: The authors would like to than...
The contents of this article are solely the responsibility of the authors and do not necessarily rep...
for editing the English text. Author disclosures: Dr M De Laurenti-is received honoraria as a member...
Authors ’ disclosures of potential conflicts of interest are found at the end of this article
ton, DC. Published online ahead of print at www.jco.org on December 15, 2014. Authors ’ disclosures ...
As a leading source of cancer information worldwide, the American Society of Clinical Oncology (ASCO...
Competing Interests: The authors have declared that no competing interests exist
∙ The authors have no financial conflicts of interest. © Copyright: Yonsei University College of Med...
The authors state that there is no conflict of interest to declare, all steps were taken to ensure t...
The authors declare that they have no conflict of interests regarding this manuscript
Published online ahead of print at www.jco.org on March 10, 2014. Both M.O. and T.I. contributed equ...
Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or...
reaction. Oral anticancer agents such as gefitinib are gener-ally thought to be safer than other ant...
diotherapy, three-dimensional confor-mal radiotherapy. Conflict of interest: None. On behalf of all ...
response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal...
authors declare no potential conflicts of interest. Acknowledgments: The authors would like to than...
The contents of this article are solely the responsibility of the authors and do not necessarily rep...
for editing the English text. Author disclosures: Dr M De Laurenti-is received honoraria as a member...
Authors ’ disclosures of potential conflicts of interest are found at the end of this article
ton, DC. Published online ahead of print at www.jco.org on December 15, 2014. Authors ’ disclosures ...
As a leading source of cancer information worldwide, the American Society of Clinical Oncology (ASCO...
Competing Interests: The authors have declared that no competing interests exist
∙ The authors have no financial conflicts of interest. © Copyright: Yonsei University College of Med...
The authors state that there is no conflict of interest to declare, all steps were taken to ensure t...
The authors declare that they have no conflict of interests regarding this manuscript
Published online ahead of print at www.jco.org on March 10, 2014. Both M.O. and T.I. contributed equ...
Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or...
reaction. Oral anticancer agents such as gefitinib are gener-ally thought to be safer than other ant...